Cargando…
Serum calprotectin can indicate current and future severity of COVID‐19
BACKGROUND: Predictive and prognostic biomarkers to guide 2019 novel coronavirus disease (COVID‐19) are critically evolving. Dysregulated immune responses are the pivotal cause of severity mainly mediated by neutrophil activation. Thus, we evaluated the association of calprotectin, neutrophil secret...
Autores principales: | Shokri‐Afra, Hajar, Moradi, Mona, Musavi, Hadis, Moradi‐Sardareh, Hemen, Moradi poodeh, Bahman, Kazemi Veisari, Arash, Oladi, Ziaeddin, Ebrahimi, Mahboobe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833977/ https://www.ncbi.nlm.nih.gov/pubmed/36525302 http://dx.doi.org/10.1002/jcla.24809 |
Ejemplares similares
-
Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
por: Shokri-Afra, Hajar, et al.
Publicado: (2021) -
The Correlation of SKA2 with Cortisol, IL-1β and Anxiety in Pregnant Women with the Risk of Preterm Delivery
por: Ijabi, Janat, et al.
Publicado: (2020) -
Cholesterol Transporters ABCA1 and ABCG1 Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Metabolic Syndrome
por: Tavoosi, Zahra, et al.
Publicado: (2015) -
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
por: Nabi-Afjadi, Mohsen, et al.
Publicado: (2023) -
Frequencies of mobilized colistin resistance (mcr-1, 2) genes in clinically isolated Escherichia coli; a cross sectional study
por: Mirzaei, Bahman, et al.
Publicado: (2023)